Shane William Charles Kovacs

CIK: 0001579397

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (50.0%)

Position reduction

Option Exercises (M)1 (10.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OLMA

Olema Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

OLMA
Olema Pharmaceuticals, Inc.
Jan 15, 2026
Sale(S)
Direct
100K shares at avg. $28.73$2.9M
OLMA
Olema Pharmaceuticals, Inc.
Jan 13, 2026
Sale(S)
Direct
3.8K shares at avg. $28.01$107K
OLMA
Olema Pharmaceuticals, Inc.
Dec 8, 2025
Gift(G)
Direct
75K shares-
OLMA
Olema Pharmaceuticals, Inc.
Nov 26, 2025
Gift(G)
Direct
225K shares-
OLMA
Olema Pharmaceuticals, Inc.
Feb 28, 2025
Award(A)
Stock Option (Right to Buy)
Direct
320K shares-
OLMA
Olema Pharmaceuticals, Inc.
Dec 11, 2024
Sale(S)
Direct
18K shares at avg. $8.66$155K
OLMA
Olema Pharmaceuticals, Inc.
Dec 11, 2024
Sale(S)
Direct
406 shares at avg. $9.39$4K
OLMA
Olema Pharmaceuticals, Inc.
Dec 10, 2024
Sale(S)
Direct
16.8K shares at avg. $9.37$157K
OLMA
Olema Pharmaceuticals, Inc.
Dec 9, 2024
Award(A)
Direct
68.3K shares-
OLMA
Olema Pharmaceuticals, Inc.
Nov 15, 2024
Exercise(M)
Direct
25K shares at avg. $7.02$176K

		Type	Shares	Price		Ownership
Jan 15, 2026	OLMA Olema Pharmaceuticals, Inc.	Sale(S)	100,000	$28.73	$2,873,000	Direct
Jan 13, 2026	OLMA Olema Pharmaceuticals, Inc.	Sale(S)	3,822	$28.01	$107,054	Direct
Dec 8, 2025	OLMA Olema Pharmaceuticals, Inc.	Gift(G)	75,000	-	-	Direct
Nov 26, 2025	OLMA Olema Pharmaceuticals, Inc.	Gift(G)	225,000	-	-	Direct
Feb 28, 2025	OLMA Olema Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Buy)	320,000	-	-	Direct
Dec 11, 2024	OLMA Olema Pharmaceuticals, Inc.	Sale(S)	17,950	$8.66	$155,447	Direct
Dec 11, 2024	OLMA Olema Pharmaceuticals, Inc.	Sale(S)	406	$9.39	$3,812	Direct
Dec 10, 2024	OLMA Olema Pharmaceuticals, Inc.	Sale(S)	16,803	$9.37	$157,444	Direct
Dec 9, 2024	OLMA Olema Pharmaceuticals, Inc.	Award(A)	68,250	-	$0	Direct
Nov 15, 2024	OLMA Olema Pharmaceuticals, Inc.	Exercise(M)	25,000	$7.02	$175,500	Direct

1-10 of 10 transactions

About Kovacs Shane William Charles

Kovacs Shane William Charles (SEC CIK 0001579397) files insider reports with the SEC as CH. OPERATING & FINANCIAL OFF. of Olema Pharmaceuticals, Inc. (OLMA).

Signal8 holds 6 ownership filings by Kovacs Shane William Charles, all Form 4s, filed between Nov 18, 2024 and Jan 15, 2026. Those filings report 10 transactions, from Nov 15, 2024 to Jan 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kovacs Shane William Charles's filings is in SAN FRANCISCO, CA.

Recent filings by Kovacs Shane William Charles

Jan 15, 2026: Open-market sale of OLMA shares (Form 4, code S).
Jan 13, 2026: Open-market sale of OLMA shares (Form 4, code S).
Dec 8, 2025: Gift of OLMA shares (Form 4, code G).
Nov 26, 2025: Gift of OLMA shares (Form 4, code G).
Feb 28, 2025: Grant or award of OLMA derivative securities (Form 4, code A).

Other insiders filing for Olema Pharmaceuticals, Inc. (OLMA)

O'Byrne Jason, CHIEF FINANCIAL OFFICER
Harmon Cyrus, Director
BVF PARTNERS L P/IL, Director
BUTITTA CYNTHIA M, Director
Garland J. Scott, Director
Hrustanovic Gorjan, Director

How to read Form 4 transaction codes